Last update:

Vaccination news

Pediatrics

CDC study shows nirsevimab effective in reducing RSV hospitalizations among young children

Research led by the CDC and conducted at seven academic pediatric medical centers in the United States finds nirsevimab (sold as Beyfortus) highly effective in reducing respiratory syncytial virus (RSV) related hospitalization ...

Diseases, Conditions, Syndromes

One-third of Americans uninformed about and undervaccinated for HPV, according to study

The human papillomavirus (HPV), a common sexually transmitted infection, accounts for 70% of all throat cancers, according to the National Cancer Institute. While commonly associated with cervical cancer, throat cancer is ...

Diseases, Conditions, Syndromes

Expert explains shingles and the shingles vaccine

Shingles can strike anyone who had chickenpox when they were young, and the intense pain that can accompany this body rash has sidelined many a senior.

Diseases, Conditions, Syndromes

How measles, whooping cough, and worse could roar back

The availability of safe, effective COVID vaccines less than a year into the pandemic marked a high point in the 300-year history of vaccination, seemingly heralding an age of protection against infectious diseases.

Oncology & Cancer

Possible colon cancer vaccine target uncovered in bacteria

Higher rates of certain cancers in countries, such as the UK, may be linked to two particular strains of bacteria. Targeting these with treatments or vaccines could help reduce the risk of colorectal, bladder, and prostate ...

Pediatrics

Pediatrician explains whooping cough

Whooping cough, or pertussis, is a highly contagious respiratory infection caused by bacteria called Bordetella pertussis. The infection attacks the lining of the breathing passages. People can get whooping cough any time ...

Diseases, Conditions, Syndromes

New malaria vaccine shows high protection in clinical trial

Researchers at Leiden University Medical Center and Radboud University Medical Center in the Netherlands have demonstrated promising safety and efficacy of a late-liver-stage attenuated malaria parasite vaccine in a small ...